MOLECULAR INSIGHT PHARMACEUTICALS - PIONEERS IN MEDICINE, PARTNERS IN CARE

Serial Number 77108578
606

Registration Progress

Application Filed
Feb 15, 2007
Under Examination
Sep 23, 2008
Approved for Publication
Jun 11, 2008
Published for Opposition
Jul 1, 2008
Registered

Trademark Image

MOLECULAR INSIGHT PHARMACEUTICALS - PIONEERS IN MEDICINE, PARTNERS IN CARE

Basic Information

Serial Number
77108578
Filing Date
February 15, 2007
Published for Opposition
July 1, 2008
Abandonment Date
April 25, 2011
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 25, 2011
Classes
016

Rights Holder

Molecular Insight Pharmaceuticals, Inc.

03
Address
160 Second Street
Cambridge, MA 02142

Ownership History

Molecular Insight Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Molecular Insight Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
James F. Ewing

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

39 events
Date Code Type Description Documents
Jun 1, 2011 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Apr 25, 2011 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 25, 2011 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Sep 21, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 20, 2010 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 16, 2010 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 16, 2010 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 13, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 12, 2010 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 11, 2010 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 16, 2010 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 16, 2010 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 20, 2009 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 14, 2009 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 14, 2009 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 6, 2009 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 6, 2009 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 20, 2009 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 20, 2009 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 23, 2008 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 1, 2008 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 11, 2008 NPUB O NOTICE OF PUBLICATION Loading...
May 28, 2008 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 28, 2008 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
May 2, 2008 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 2, 2008 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 1, 2008 ALIE A ASSIGNED TO LIE Loading...
Feb 27, 2008 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 27, 2008 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 27, 2008 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Feb 27, 2008 PETG O PETITION TO REVIVE-GRANTED Loading...
Feb 27, 2008 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 7, 2008 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Jan 7, 2008 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Jun 11, 2007 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 11, 2007 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 11, 2007 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 4, 2007 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 21, 2007 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 016
Newsletters, bulletins concerning pharmaceutical development, pharmaceutical industry developments and issues and pharmaceutical investment
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
016

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS" AND "PIONEERS IN MEDICINE, PARTNERS IN CARE"